Search Results

FDA Approves Immunotherapy for Earlier Use in B-cell Acute Lymphoblastic Leukemia

Blinatumomab will now be available for adults and kids with newly diagnosed Rye Brook, N.Y., June , – The U.S. Food and Drug Administration on Frida…

LLS Expands its Global Master Trial for Hard-To-Treat Leukemias in Children

Marks the Global Pediatric Trial for Menin InhibitorsThe PedAL (Pediatric Acute Leukemia) Master Trial is at the heart of LLS’s Dare to Dream Project…

Faron Announces Results of Placing, Including Additional Investment by The Leukemia & Lymphoma Society Therapy Acceleration Program®

TURKU, FINLAND / BOSTON, MA - January - Faron Pharmaceuticals Ltd (First North: FARON, AIM: FARN), a clinical stage biopharmaceutical company focuse…

Let's Talk About Childhood Cancer: The Impact of Leukemia in Black Children

The Leukemia & Lymphoma Society Receives Grant Award from Disabled Veterans National Foundation

Rye Brook, NY- July , – The Leukemia & Lymphoma Society (LLS) is honored to announce it has received a grant from the Disabled Veterans National Foun…

The Leukemia & Lymphoma Society Applauds Bipartisan Agreement to Stop Surprise Medical Bills

Patients are now one step closer to breathing a sigh of relief. For too long, they’ve faced the anxiety of knowing that any visit to a healthcare prov…

Burlington Stores Raises More Than $37M For The Leukemia & Lymphoma Society

(RYE BROOK, N.Y., Dec. , ) – Burlington Stores and The Leukemia & Lymphoma Society (LLS) joined forces for the 17th consecutive year to help save live…

The Leukemia & Lymphoma Society Names Lore Gruenbaum, Ph.D., New Chief Scientific Officer

Lore Gruenbaum, Ph.D., will oversee the planning and execution of the strategy for all LLS’s research programs Dr. Gruenbaum succeeds Lee Greenberger,…

THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) INVESTS $3.8 MILLION TO ADVANCE HEALTH EQUITY

LLS’s Equity in Access Research Program Awards Five New Grants to Researchers Across the U.S. Aiming to Break Down Barriers to Care for Blood Cancer P…

Detection and treatment of Adult T cell leukemia/lymphoma in the premalignant stage.

Clonally expanded T cells carrying somatic mutations circulate in the premalignant phase of Adult T cell leukemia/lymphoma (ATL). We will develop of …

The Leukemia & Lymphoma Society’s 30th Annual Scenic Shore 150 Bike Tour on Quest to Save Lives

Rye Brook, NY (June , ) – Every seconds, someone in the U.S. has their life turned upside down by a blood cancer diagnosis. When this happens, the gl…

The Leukemia & Lymphoma Society Honors Five Outstanding Blood Cancer Scientists with 2023 Awards

RYE BROOK, N.Y., December , – The Leukemia & Lymphoma Society (LLS) recognized and celebrated the outstanding contributions of five scientific invest…

FDA Approves New Drug for the Most Common Form of Leukemia in Adults

The U.S. Food and Drug Administration has approved pirtobrutinib (Jaypirca™). Pirtobrutinib is the only , reversable Bruton’s tyrosine kinase (BTK) i…

Targeting the interaction of leukemia stem cells with their niche to treat myelofibrosis

Bone marrow scar formation (fibrosis) is a hallmark of myelofibrosis and contributes significantly to the disease progression. We use mouse genetics t…

LLS Releases Results of its Precision Medicine Trial in Deadly Leukemia at ASH

View full release here. …

PhRMA Recognized as 2013 "Titan of Business & Philanthropy" At the Annual Leukemia Ball

PhRMA Recognized as "Titan of Business & Philanthropy" At the Annual Leukemia Ball The Leukemia & Lymphoma Society (LLS) today announced they will ho…

The Leukemia & Lymphoma Society’s 31st Annual Scenic Shore 150 Bike Tour Set to Ride the Shore for a Cure

The Leukemia & Lymphoma Society’s 31st Annual Scenic Shore Bike Tour Set to Ride the Shore for a Cure

Burlington Stores & its Customers Raise Nearly $4 Million for The Leukemia & Lymphoma Society (LLS) in the Fight Against Blood Cancer

The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering am…

In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients

January , – This week, LLS has heard great concern from patients, caregivers, volunteers, healthcare professionals, researchers, community organizati…

In the Face of Uncertainty in Washington, The Leukemia & Lymphoma Society Stands with Patients

January , – This week, LLS has heard great concern from patients, caregivers, volunteers, healthcare professionals, researchers, community organizati…

FDA Approves First of a New Class of Drugs to Treat Advanced Acute Leukemia

The Leukemia & Lymphoma Society (LLS) helped every step of the way in discovery and development of menin inhibitors Rye Brook, N.Y., December , – The…

MOD PIZZA PARTNERS WITH THE LEUKEMIA & LYMPHOMA SOCIETY TO HELP KIDS WITH BLOOD CANCER

Funds Raised to Benefit the Work of LLS’s The Dare to Dream Project to Bring Safer, Less Toxic Treatments for Kids with Blood Cancer & Provide Free Su…

UFCW AND THE LEUKEMIA & LYMPHOMA SOCIETY ARE UNITED IN THE FIGHT TO END CANCER

Washington D.C. (September , ) - The United Food and Commercial Workers International Union (UFCW) and The Leukemia & Lymphoma Society (LLS) today ann…

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

For Immediate ReleaseContact: Andrea GreifSenior Director of Communications()- (p))- (c)[email protected](White Plains, NY) - January , - Today's…

Subaru Partners with The Leukemia & Lymphoma Society for 8th Year to Share Warmth, Love and Relief with Patients Facing Cancer

Subaru of America, Inc. is renewing its partnership with The Leukemia & Lymphoma Society (LLS) during Subaru Loves to Care® month in June. Subaru will…